NCT03042598

Brief Summary

Investigators intend to determine if the use of Biphasic Cuirass Ventilation (BCV) improves patient safety (avoiding hypoxia) during emergency rapid sequence intubation .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

January 14, 2017

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 3, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

February 3, 2017

Status Verified

February 1, 2017

Enrollment Period

3 months

First QC Date

November 2, 2016

Last Update Submit

February 2, 2017

Conditions

Keywords

Safe Apneic PeriodEmergency IntubationBiphasic Cuirass Ventilation (BCV)Non-invasive ventilationPeri-intubation Hemodynamic instabilitydesaturationwaveform capnographyPatient safety

Outcome Measures

Primary Outcomes (1)

  • Composite Primary Endpoint is the composite prevalence of any desaturation defined as SPO2 < 95% or Bradycardia, HR <60 beats per minute sustained for at least 30 seconds

    The primary outcome measure is the composite prevalence of any desaturation defined as SPO2 \< 95% or Bradycardia, HR \<60 beats per minute sustained for at least 30 seconds, during and in the immediate post intubation (5 minutes after tracheal intubation is confirmed) period.

    0 to 5 minutes after intubation

Secondary Outcomes (5)

  • Prevalence of post-paralytic Bag valve mask use

    Time from paralytics administered until proper endotracheal tube placement is confirmed.

  • Waveform capnography pattern

    Baseline to 30 minutes after intubation

  • Change in End-Tidal Carbon Dioxide (ETCO2) values

    Period of time from acquiring baseline ETCO2 value to successful intubation.

  • Blood Pressure response to the BCV device

    Baseline vital signs to 30 Minutes after intubation

  • SpO2 response to pre-oxygenation attempts BCV application

    Baseline vital signs to 30 Minutes after intubation

Study Arms (1)

Biphasic Cuirass Ventilation

EXPERIMENTAL

Patients requiring emergent intubation in the Emergency Department will be provided ventilation during the apnic phase of intubation via the use of BCV.

Device: Biphasic Cuirass Ventilation

Interventions

The RTX Respirator will be applied to the patient's chest to provide non-invasive ventilatory support using a Biphasic Cuirass Ventilation technology to increase the safe apnic period during intubation.

Also known as: RTX Respirator, Hayek Medical
Biphasic Cuirass Ventilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who present to the adult emergency department and require emergency intubation.
  • Patient's primary language is English.

You may not qualify if:

  • Cardiac arrest.
  • Attending provider excludes patient as being at high risk for cardiac arrest or for any other reason.
  • Patients who are known or reported to be pregnant pre-procedure.
  • Patients in the custody of law enforcement.
  • Inability to pre-oxygenate patient to an SPO2 equal to or greater than 95 percent prior to induction.
  • Morbidly or Extremely obese patients defined by the NIH as BMI greater than 40.
  • History of valvular heart disease.
  • Presence of subclavian central line or pacemaker which impairs ability of shell to seal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center of Southern Nevada

Las Vegas, Nevada, 89102, United States

RECRUITING

Related Publications (8)

  • Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med. 2012 Mar;59(3):165-75.e1. doi: 10.1016/j.annemergmed.2011.10.002. Epub 2011 Nov 3.

    PMID: 22050948BACKGROUND
  • Bodily JB, Webb HR, Weiss SJ, Braude DA. Incidence and Duration of Continuously Measured Oxygen Desaturation During Emergency Department Intubation. Ann Emerg Med. 2016 Mar;67(3):389-95. doi: 10.1016/j.annemergmed.2015.06.006. Epub 2015 Jul 9.

    PMID: 26164643BACKGROUND
  • Sakles JC, Chiu S, Mosier J, Walker C, Stolz U. The importance of first pass success when performing orotracheal intubation in the emergency department. Acad Emerg Med. 2013 Jan;20(1):71-8. doi: 10.1111/acem.12055.

    PMID: 23574475BACKGROUND
  • Brimacombe J, Keller C. Who is at increased risk of aspiration? Br J Anaesth. 2005 Feb;94(2):251; author reply 251-2. doi: 10.1093/bja/aei511. No abstract available.

    PMID: 15629910BACKGROUND
  • Kamine TH, Papavassiliou E, Schneider BE. Effect of abdominal insufflation for laparoscopy on intracranial pressure. JAMA Surg. 2014 Apr;149(4):380-2. doi: 10.1001/jamasurg.2013.3024.

    PMID: 24522521BACKGROUND
  • Li J, Murphy-Lavoie H, Bugas C, Martinez J, Preston C. Complications of emergency intubation with and without paralysis. Am J Emerg Med. 1999 Mar;17(2):141-3. doi: 10.1016/s0735-6757(99)90046-3.

    PMID: 10102312BACKGROUND
  • Benumof JL, Dagg R, Benumof R. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology. 1997 Oct;87(4):979-82. doi: 10.1097/00000542-199710000-00034. No abstract available.

    PMID: 9357902BACKGROUND
  • Corrado A, Gorini M, Melej R, Baglioni S, Mollica C, Villella G, Consigli GF, Dottorini M, Bigioni D, Toschi M, Eslami A. Iron lung versus mask ventilation in acute exacerbation of COPD: a randomised crossover study. Intensive Care Med. 2009 Apr;35(4):648-55. doi: 10.1007/s00134-008-1352-9. Epub 2008 Nov 20.

    PMID: 19020859BACKGROUND

Study Officials

  • David E Slattery, MD

    University Medical Center of Southern Nevada

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David E Slattery, MD

CONTACT

Wesley J Forred, RN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: This is a single arm interventional feasibility trial to determine if the use of a Biphasic Cuirass Ventilator during the apneic period of intubation will decrease the prevalence of oxygen desaturation in patients undergoing RSI as compared to historical proportions of 20%.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

November 2, 2016

First Posted

February 3, 2017

Study Start

January 14, 2017

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

February 3, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share

Individual Participant Data (IPD) will not be shared

Locations